Association of Summed Rest Score on Technetium‐99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis

Background In nonischemic cardiomyopathy, the clinical relevance of decreased resting myocardial technetium‐99m sestamibi ( 99m Tc‐MIBI) uptake regarding exercise capacity and clinical outcomes remains incompletely understood. We investigated whether decreased 99m Tc‐MIBI uptake is associated with impaired exercise capacity and adverse clinical outcomes in nonischemic cardiomyopathy. Methods We retrospectively analyzed 182 patients (mean age 51.4±14.0 years; 27% female) with nonischemic cardiomyopathy and left ventricular ejection fraction <50% who underwent 99m Tc‐MIBI scintigraphy and cardiopulmonary exercise testing from 2016 to 2023. Myocardial uptake of 99m Tc‐MIBI was evaluated using the summed rest score (SRS). Exercise capacity was assessed by percentage of predicted peak oxygen consumption (PPVO 2 ), with ≤60% defining impairment. Results Seventy‐four patients (41%) had PPVO 2 ≤60% and higher SRS (median: 12 versus 8; P < 0.001). Higher SRS remained significantly associated with PPVO 2 ≤60% after adjustment for relevant clinical covariates, including brain natriuretic peptide level, left ventricular ejection fraction, and heart failure duration. Over a median follow‐up of 807 days, 23 patients (13%) experienced the composite outcome of all‐cause death, ventricular assist device implantation, or heart transplantation. Higher SRS was associated with composite outcomes after adjusting for PPVO 2 ≤60%. Among the 4 groups stratified by median SRS of 9 and PPVO 2 of 60%, patients with high SRS and low PPVO 2 had the highest incidence of adverse events. Conclusions Decreased myocardial 99m Tc‐MIBI uptake was associated with impaired exercise capacity and adverse outcomes in patients with nonischemic cardiomyopathy. Our findings suggest that myocardial injury assessment using 99m Tc‐MIBI scintigraphy may provide prognostic information complementary to exercise capacity.

Authors

Institutions

Publication Details

Journal
Journal of the American Heart Association
Published
2026-08-27
DOI
https://doi.org/10.1161/jaha.126.050214
Primary Topic
Pericarditis and Cardiac Tamponade
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Summed Rest Score on Technetium‐99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis

Tomohito Ohtani, Shozo Konishi, Yasuhiro Akazawa, Yasushi Sakata et al.
Journal of the American Heart Association
Pericarditis and Cardiac Tamponade
article

Association of Summed Rest Score on Technetium‐99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis

Tomohito Ohtani, Shozo Konishi, Yasuhiro Akazawa, Yasushi Sakata, Takafumi Oka, Hibiki Mima, Fusako Sera
article en

Abstract

Background In nonischemic cardiomyopathy, the clinical relevance of decreased resting myocardial technetium‐99m sestamibi ( 99m Tc‐MIBI) uptake regarding exercise capacity and clinical outcomes remains incompletely understood. We investigated whether decreased 99m Tc‐MIBI uptake is associated with impaired exercise capacity and adverse clinical outcomes in nonischemic cardiomyopathy. Methods We retrospectively analyzed 182 patients (mean age 51.4±14.0 years; 27% female) with nonischemic cardiomyopathy and left ventricular ejection fraction <50% who underwent 99m Tc‐MIBI scintigraphy and cardiopulmonary exercise testing from 2016 to 2023. Myocardial uptake of 99m Tc‐MIBI was evaluated using the summed rest score (SRS). Exercise capacity was assessed by percentage of predicted peak oxygen consumption (PPVO 2 ), with ≤60% defining impairment. Results Seventy‐four patients (41%) had PPVO 2 ≤60% and higher SRS (median: 12 versus 8; P < 0.001). Higher SRS remained significantly associated with PPVO 2 ≤60% after adjustment for relevant clinical covariates, including brain natriuretic peptide level, left ventricular ejection fraction, and heart failure duration. Over a median follow‐up of 807 days, 23 patients (13%) experienced the composite outcome of all‐cause death, ventricular assist device implantation, or heart transplantation. Higher SRS was associated with composite outcomes after adjusting for PPVO 2 ≤60%. Among the 4 groups stratified by median SRS of 9 and PPVO 2 of 60%, patients with high SRS and low PPVO 2 had the highest incidence of adverse events. Conclusions Decreased myocardial 99m Tc‐MIBI uptake was associated with impaired exercise capacity and adverse outcomes in patients with nonischemic cardiomyopathy. Our findings suggest that myocardial injury assessment using 99m Tc‐MIBI scintigraphy may provide prognostic information complementary to exercise capacity.

Journal of the American Heart Association
The University of Osaka (JP)
Good health and well-being
Openalex Percentile: Top 10%
Pericarditis and Cardiac Tamponade
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.